Leading Health and Life Sciences in Nova Scotia

BioFuture 2030 is the first industry-led economic strategy to grow Nova Scotia’s health and life sciences sector.

The plan leverages our science, talent, and infrastructure to transform our economy by growing globally-competitive companies, attracting millions of investment dollars, and creating high-value jobs for Atlantic Canadians.

The health and life sciences sector is one of our greatest economic opportunities. The companies in our sector are tackling the biggest challenges facing our region by improving the sustainability of our healthcare system, developing tools to assist our aging population, providing healthier foods for a growing global population, and creating sustainable bioproducts.

BioFuture 2030 is a collaborative plan and call-to-action for the players in Atlantic Canada’s health and life sciences sector – whether you are in the research community, the business community, or different levels of government.

BioFuture 2030 News

ENTREVESTOR – Biotech Segment Continues To Grow

Read original Entrevestor article here One of the strongest developments in the Atlantic Canadian startup community in recent years is the development of the life sciences segment – both the biotech companies and the ecosystem that supports them. Five years ago, these...

Entrevestor – BioNova Calls for Tax Credit Reforms

See original Entrevestor article here While applauding recent investment tax credit reforms in Nova Scotia, the province’s life sciences association wants further improvements, including offering the credits to investors outside the region. BioNova, the group that...

Province Announces Innovation Equity Tax Credit

Read original announcement here Nova Scotia startup companies and small and medium-sized businesses will benefit from more investment, thanks to a new Innovation Equity Tax Credit launched today by Finance and Treasury Board Minister Karen Casey. The new tax credit...

ENTREVESTOR: Momentum for Tax Credit Revamp

The investment tax credit discussion in Atlantic Canada has been intensifying lately, and now Senator Colin Deacon is taking up the cause. These provincial taxation measures give private investors a tax break if they invest in approved companies. All four Atlantic...

ENTREVESTOR: A Plan To Double NS Biotech by 2030

Read the original article here. BioNova, the association for Nova Scotia’s life sciences industry, has released its plan to at least double the biotech sector in the next 12 years, creating 2,700 jobs with average salaries of more than $100,000. Titled BioFuture 2030,...

#BioFuture2030          #LeadingLifeScience